Provided by Tiger Trade Technology Pte. Ltd.

AngioDynamics

15.11
-0.0100-0.07%
Post-market: 15.150.0400+0.26%19:42 EDT
Volume:1.13M
Turnover:17.07M
Market Cap:635.44M
PE:-17.08
High:15.36
Open:15.36
Low:15.00
Close:15.12
52wk High:16.29
52wk Low:9.39
Shares:42.05M
Float Shares:32.51M
Volume Ratio:1.68
T/O Rate:3.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8848
EPS(LYR):-0.8848
ROE:-20.77%
ROA:-5.13%
PB:3.72
PE(LYR):-17.08

Loading ...

AngioDynamics Targets BPH Market With New NanoKnife Trial: What Investors Should Watch

TIPRANKS
·
Jun 12

AngioDynamics lifts FY2026 net sales outlook to $313.5-$315.5 million

Reuters
·
Jun 10

BRIEF-AngioDynamics Says Palmetto GBA finalizes Medicare Nanoknife coverage from July 5, 2026

Reuters
·
May 29

AngioDynamics Medicare coverage for NanoKnife IRE in prostate, liver cancer takes effect July 2026

Reuters
·
May 29

AngioDynamics - Palmetto Gba Issues Final Lcd for Medicare Coverage of Nanoknife Ire Effective July 5, 2026

THOMSON REUTERS
·
May 29

AngioDynamics to present at Goldman Sachs Global Healthcare Conference

Reuters
·
May 27

AngioDynamics Reports 'Durable Oncologic Control' in Study of NanoKnife for Intermediate-Risk Prostate Cancer

MT Newswires Live
·
May 13

AngioDynamics reports durable 2-year NanoKnife outcomes in PRESERVE prostate cancer trial

Reuters
·
May 13

AngioDynamics Announces Two-Year Preserve Trial Data Demonstrating Durable Nanoknife Ire System Outcomes in Intermediate-Risk Prostate Cancer

THOMSON REUTERS
·
May 13

AngioDynamics Files Patent Suit to Protect Thrombectomy Technology

TIPRANKS
·
Apr 24

BRIEF-Angiodynamics Files Patent Infringement Lawsuit Against Endovascular Engineering On April 23, 2026

Reuters
·
Apr 24

AngioDynamics - Files Patent Infringement Lawsuit Against Endovascular Engineering on April 23, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 24

AngioDynamics sues Endovascular Engineering over alleged Hēlo Thrombectomy System patent infringement

Reuters
·
Apr 24

AngioDynamics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 06

AngioDynamics initiated with a Buy at Freedom Broker

TIPRANKS
·
Apr 06

AngioDynamics price target lowered to $16 from $18 at Canaccord

TIPRANKS
·
Apr 06

Canaccord Genuity Remains a Buy on AngioDynamics (ANGO)

TIPRANKS
·
Apr 06

AngioDynamics Earnings Call Highlights Med Tech Momentum

TIPRANKS
·
Apr 06